VeraQ powers the qualified clinical data registries (QCDRs) for Verana Health’s medical society partners, including the American Academy of Ophthalmology IRIS^® Registry (Intelligent Research in Sight), American Academy of Neurology Axon Registry^®, and American Urological Association (AUA) Quality Registry (AQUA).

For IRIS Registry and Axon Registry, it enables compliance with Merit-based Incentive Payment System (MIPS) reporting standards, which are care quality measurements required by the Centers for Medicare and Medicaid Services (CMS). Participation in a QCDR helps to save contributing clinician practices thousands of dollars annually; in fact, the IRIS Registry has helped participating ophthalmologists save more than $1 billion in penalties from 2017 to 2020.

VeraQ also enables practices to enhance patient care by helping identify patients who may qualify for a clinical trial, which can accelerate trial activity for clinician investigators and life science sponsors.